we used gene expression profiling to determine gene expression changes in sensitive and drug tolerant medulloblastoma cells to reexposure to BET-bromodomain inhibitors Overall design: Cells were treated with 1uM of DMSO or JQ1 and RNA-extracted at 24 hours